Measles is a highly contagious viral disease; to interrupt endemic transmission of measles virus, population immunity of R95% must be achieved [1] . Measles case fatality rates in Africa generally range from 3% to 5% and can be as high as 30% during severe outbreaks [2] . Serological studies indicate that seroconversion after 1-dose measles vaccination is 85% when the vaccine is given at age 9 months and that seroconversion after 2-dose measles vaccination is 99% when the second dose is given at age R12 months [3] .
The World Health Organization (WHO) and the United Nations Children's Fund (UNICEF) recommend accelerated measles control in Africa using measles mortality reduction strategies that include (1) achieving and maintaining R80% coverage with routine measles vaccination of infants, (2) providing a second dose of measles vaccine through supplemental immunization activities (SIAs), (3) intensified measles case-based surveillance with laboratory confirmation, and (4) improved case management [4] . The SIA strategy of periodic nationwide mass vaccination campaigns is used to reach all children in the target age group regardless of their vaccination status and includes special planning to reach subpopulations that do not access routine vaccination services. The strategy starts with a one-time catch-up campaign targeting children aged 9 months to 14 years, followed by periodic follow-up campaigns conducted every 2-4 years that target children who were born after the previous SIA. Generally, follow-up SIAs target children aged 9 months to 4 or 5 years, depending on the interval between the SIAs. The strategy of catchup and follow-up campaigns was developed in the WHO region of the Americas, and this strategy, when successfully implemented in combination with the strengthening of routine coverage, allowed the successful elimination of measles [2] . The member states of the WHO African region adopted these strategies and launched accelerated measles control activities in 2001 [2, 3, 5] .
The WHO African Region has adopted a measles pre-elimination goal of .98% mortality reduction by 2012, compared with estimates for 2000; reducing measles incidence to ,5 cases per 10 6 population per year at the national level in all countries;
attaining .90% routine measles-containing vaccine (MCV1) coverage at the national level and .80% coverage in all districts; attaining .95% SIA coverage in all districts; achieving a nonmeasles febrile rash illness rate of R2.0 cases per 100,000 population per year and R1 suspected measles case with serological investigation in at least 80% of districts per year [6] . Nigeria is located in West Africa, and the 2006 census estimates the Nigerian population at 140 million, with an annual growth rate of 3.2% [7] . It has 6 geopolitical zones (3 in the North and 3 in the South), divided into 36 states and the Federal Capital Territory, which are further subdivided into 774 local government areas (LGAs).
In Nigeria, 52% of the population has access to health care in 2005 [7] . Measles vaccination through routine services started in 1979 through Nigeria's Expanded Program on Immunizations (EPI), with 1 dose of measles vaccine provided to children at or shortly after 9 months of age [8] [9] . Vaccination coverage data are from WHO and UNICEF estimates [9] . 
NOTE.
a Bacille Calmette Gué rin vaccine, measles vaccine, and 3 doses of each of diphtheria pertussis tetanus vaccine and polio vaccine (excluding polio vaccine given at birth).
In 2006, Nigeria established a system of measles case-based surveillance, with every suspected case being reported through an individual case reporting form accompanied by the collection of a blood specimen for serological confirmation of measles. Four subnational measles serological laboratories were established across the country for the serological testing of specimens from suspected measles cases. The WHO supported their establishment by providing training, equipment, and reagents. The field surveillance system for measles was built upon the established surveillance for the detection of acute flaccid paralysis cases as part of Nigeria's polio eradication efforts. Measles case-based surveillance data and laboratory results are captured through a computerized system of data management at the national level.
This report summarizes accelerated measles control activities in Nigeria, starting in 2005, and provides a descriptive analysis of measles cases reported to the national measles case-based surveillance system during 2005-2008.
METHODS
The MCV1 coverage estimates, calculated by the national EPI using the administrative method of dividing the total number of doses administered to children in the target age group by the census-estimated number of children in that age group, were analyzed. These national measles vaccination coverage data are reported annually to the WHO and UNICEF using the joint reporting form (JRF). The WHO and UNICEF estimates of MCV1 coverage were reviewed. Estimates of national and statelevel coverage of measles vaccination during the 2 phases of the measles catch-up SIA were also reviewed. Following the WHO measles case-based surveillance guidelines, the surveillance case definition of a suspected measles case was any person who experienced fever and generalized skin rash plus cough or conjunctivitis or runny nose. A laboratoryconfirmed measles case was a suspected measles case in an individual with a laboratory test result positive for measlesspecific immunoglobulin (Ig) M antibodies who did not have a history of receiving measles vaccination within 14 days prior to the onset of rash. A compatible case was a suspected measles case in an individual from whom a blood specimen was not collected or who had equivocal measles IgM test results and who had no epidemiologic link to a laboratory-confirmed measles case. A measles case confirmed by epidemiologic link is a suspected measles case in an individual from whom a blood specimen was not collected but who was epidemiologically linked with a laboratory-confirmed case of measles and had onset of skin rash within 1 month of the skin rash in the individual with the laboratory-confirmed case, who resided in the same district, or who resided in an adjacent district but with a plausible transmission chain. A discarded measles case is a suspected measles case in an individual with a negative measles IgM laboratory result or IgM positivity and a history of measles vaccination in the 14 days preceding the sample collection. Measles death is any death in an individual with a confirmed case of measles within 30 days of rash onset without any other contributing cause of death (eg, trauma). A measles outbreak was defined as the occurrence of R5 suspected measles cases (or R3 laboratory-confirmed measles cases) in a health facility or LGA in a given month. Measles incidence per million population was calculated by dividing the number of reported measles cases by the population (based on the 2006 census) and multiplied by 1 million.
The sensitivity of the surveillance system is regularly reviewed at the national and subnational levels using performance indicators, including the annualized nonmeasles febrile rash illness rate (target of R2 cases per 100,000 population) and the proportion of districts that have reported at least 1 suspected case of measles with a blood specimen over a period of 1 year (target of R80%).
Surveillance and laboratory data were analyzed using EpiInfo for Windows, version 3.3.2 (Centers for Disease Control and Prevention). Informed consent was not solicited from measles patients because this body of research entailed only a review of de-identified measles surveillance data.
RESULTS

Routine Immunization
According to the WHO-UNICEF estimates, MCV1 coverage in Nigeria increased from 33% in 2000 to 44% in 2006 and remained at 41% during 2007-2008 [9] (Figure 1) .
The national MCV1 coverage reported through the JRF by Nigeria to the WHO and UNICEF was 38% in 2005, 100% in 2006, 86% in 2007, and 68% in 2008 [9] . The 2008 Demographic Health Survey (DHS) report in Nigeria estimated that the national measles coverage for children 12-23 months of age was 46% nationally, 60% in urban areas, and 33% in rural areas [10] ( LGAs achieved .95% coverage, 154 (20%) had coverage of 90%-94%, and 206 (30%) had ,90% coverage.
Measles Surveillance
Prior to the measles catch-up campaigns, the number of measles cases reported annually through the aggregate reporting system exceeded 110,000 [9] . Clinical compatible  Discarded  Pending  Total   2006  403  189  294  11  239  45  1181   2007  1  1514  1028  318  3357  397  6615   2008  0  2082  7428  644  3350  327  13831   Total  404  3785  8750  973  6946  769 
DISCUSSION
Nigeria reduced measles cases following the successful implementation of comprehensive measles mortality-reduction strategies (strengthening routine immunization program; providing additional doses through large-scale measles immunization campaigns, implementation of case-based surveillance, and improved case management with vitamin A supplementation) [11] . Despite the continued low incidence following the campaigns, the initial dramatic reduction in case load was short lived (,2 years). The main reason for the resurgence after the catch-up campaign was chronic low routine immunization coverage.
In 2003, the National Immunization Coverage Survey (NICS) estimated that measles MCV1 coverage in Nigeria was 25% [12] , whereas the 2006 NICS estimated MCV1 coverage at 32.7% [13] Health Survey (DHS) estimated MCV1 coverage at 46% [10] . Inadequate community awareness, poor quality of services, and weak social mobilization are among the reasons for the low routine immunization coverage. Periodic intensification of routine immunization (PIRI) activities (such as Local Immunization Days and Child Health Weeks) has to be conducted systematically to improve the very low routine immunization coverage. In Nigeria, Child Health Weeks are conducted twice a year (the first in the middle of the year and the second at the end of the year), and it aims to reach children who were not reached by routine immunization programs over the intervening period. It is performed after a series of social mobilization activities and is usually performed together with other child survival interventions.
The interval between SIAs is determined on the basis of guidance from the African Regional Measles Technical Advisory Group and a review of historical vaccination coverage and measles epidemiology [14] . The pattern observed in Nigeria of increased measles outbreaks following a low-incidence period immediately after catch-up campaigns is not uncommon [15, 16] . Similar impacts lasting for 15-22 months were observed in Uganda [17] . The children below the age of 2 years were born after the last measles campaign in December 2005; hence, they are new birth cohorts that were missed by the routine immunization program. The children .3 years of age were eligible during the previous measles campaigns and were missed. Both of these factors (low routine immunization coverage and high number of missed children during the last measles campaign) contributed to the resurgence of measles in Nigeria.
To validate SIA administrative coverage, a post-campaign coverage survey should be conducted after measles SIAs. A study in Burkina Faso [18] reported that, although useful to help plan the logistics of a campaign, administrative coverage data should be used with other evaluation techniques to determine the number of eligible children vaccinated during mass campaigns. In another study, from Cameroon [19] , administrative data tended to over-estimate vaccination coverage by 1%-29%. For those reasons, a post-campaign coverage survey should be conducted to enable the country to have more-reliable campaign coverage estimates. The coverage survey must be followed by mop-up vaccination campaigns in areas demonstrating low coverage [6] .
Protecting children against measles will make a significant contribution to reducing child deaths, which is a key millennium development goal [5, 20] . The progress in reducing measles-related deaths in Nigeria is therefore a complementary success towards attaining the millennium development goal.
